Conference
RANDOMISED DOUBLE-BLIND PHASE III TRIAL OF CEDIRANIB (AZD 2171) IN RELAPSED PLATINUM SENSITIVE OVARIAN CANCER: RESULTS OF THE ICON6 TRIAL.
Authors
Raja FA; Perren TJ; Embleton A; Rustin GJS; Jayson G; Swart AM; Vaughan M; Hirte H; Stark DP; Ledermann JA
Volume
23
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
October 2013
Conference proceedings
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Issue
8
ISSN
1048-891X